
August 28, 2023
RegMed Investors (RMi) Closing Bell: the music slowed eliminating downside
August 28, 2023
RegMed Investors’ (RMi) pre-open: musical chairs
August 25, 2023
RegMed Investors (RMi) Closing Bell: sector takes the line of least expectation as sector turns positive
August 25, 2023
RegMed Investors’ (RMi) pre-open: share pricing versus Jerome
August 24, 2023
Med Investors (RMi) Closing Bell: Nasdaq evaporates taking cell and gene therapy equities with it
August 24, 2023
RegMed Investors’ (RMi) pre-open: anticipation versus expectation
August 23, 2023
RegMed Investors (RMi) Closing Bell: equites up, employees down
August 23, 2023
RegMed Investors’ (RMi) pre-open: the outlook for cell and gene therapy equities remains challenging
August 22, 2023
Reg Med Investors (RMi) Closing Bell: the cell and gene therapy sector wavers with a positive close
August 22, 2023
RegMed Investors’ (RMi) pre-open: risk involves uncertainty
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors